Robert Bradway - Amgen Insider

Amgen Inc -- USA Stock  

USD 192.33  3.05  1.61%

Chairman, CEO and President Chairman of Executive Committee and Member of Equity Award Committee

Mr. Robert A. Bradway is the Chairman of the Board, President, Chief Executive Officer of Amgen Inc. Robert A. Bradway has served as our director since October 2011 and Chairman of the Board since January 1, 2013. Mr. Bradway was our President since May 2010 and Chief Executive Officer since May 2012. From May 2010 to May 2012, Mr. Bradway served as our Chief Operating Officer. Mr. Bradway joined Amgen in 2006 as Vice President, Operations Strategy and served as Executive Vice President and Chief Financial Officer from April 2007 to May 2010. Prior to joining Amgen, he was a Managing Director at Morgan Stanley in London where, beginning in 2001, he had responsibility for the firms banking department and corporate finance activities in Europe. Mr. Bradway was a director of Norfolk Southern Corporationrationration, a transportation company, since July 2011, serving on its Audit and Governance and Nominating Committees, and The Boeing Corporationrationration, an aerospace company and manufacturer of commercial airplanes, defense, space and securities systems, since October 2016, serving on its Audit and Finance committees. He has served on the board of trustees of the University of Southern California since April 2014 and on the advisory board of the Leonard D. Schaeffer Center for Health Policy and Economics at that university since 2012
Age: 53  Chairman Since 2013      
805 447-1010
Bradway holds a bachelor?s degree in biology from Amherst College and a master?s degree in business administration from Harvard Business School.

Robert Bradway Latest Insider Activity

Management Efficiency

The company has return on total asset (ROA) of 7.92 % which means that it generated profit of $7.92 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on stockholders equity (ROE) of 25.96 % meaning that it created $25.96 on every $100 dollars invested by stockholders.
The company currently holds 35.78 B in liabilities with Debt to Equity (D/E) ratio of 111.0 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Amgen Inc has Current Ratio of 5.95 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.

Similar Executives

Found 6 records


Paul BisaroAllergan plc
Miles WhiteAbbott Laboratories
Roger KimmelEndo International plc
Joshua BogerVertex Pharmaceuticals Incorpor
Norman SchwartzBio Rad Laboratories Inc
Jeffrey LeidenVertex Pharmaceuticals Incorpor

Entity Summary

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. Amgen Inc (AMGN) is traded on NASDAQ in USA. It is located in CALIFORNIA, U.S.A and employs 17,900 people. Amgen is listed under Pharmaceutical Products category by Fama And French industry classification.
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Amgen Inc to your portfolio

Top Management

Amgen Inc Leadership Team
Frank Herringer, Director
R Williams, Director
Francois Carbonnel, Director
Rebecca Henderson, Director, Ph.D
Annette Such, Executive
Sanders Williams, Director
Vance Coffman, Director, Ph.D
Tyler Jacks, Director, Ph.D
Brian McNamee, President
Gregory Garland, Director
Charles Holley, Director
Esteban Santos, President
Jonathan Graham, President
Sean Harper, President, Ph.D
Ellen Kullman, Director
Frank Biondi, Director
Arvind Sood, Executive
David Meline, CFO
Ronald Sugar, Director
Stuart Tross, President
Robert Bradway, Chairman
Wanda Austin, Director
Robert Eckert, Director
Madhavan Balachandran, EVP
Lori Johnston, President
Cynthia Patton, President
Greg Garland, Director
Judith Pelham, Director
David Baltimore, Director, Ph.D
Fred Hassan, Director
David Piacquad, President
Anthony Hooper, EVP

Stock Performance

Amgen Performance Indicators